CVS Health 's board has engaged advisors to conduct a strategic review of its business, according to people familiar with the matter, as the company contends with potential activist pressure and a severely depressed stock price. The review has been ongoing for some time, said the people, but there is no certainty on what actions, if any, the company will take. CVS management, including CEO Karen Lynch, met with major shareholder Glenview Capital Monday to discuss the company's lagging prospects and Glenview's plans to revive the stock, CNBC previously reported. In a statement, CVS spokesman David Whitrap told CNBC: "CVS Health's management team and Board of Directors are continually exploring ways to create shareholder value. CVS shares rose around 2.5% in after-hours trading Monday on the news, which was first reported by Reuters.

---

Persons: Karen Lynch, Lynch, David Whitrap, Brian Kane, —, Bertha Coombs Organizations: Washington DC, CVS, Glenview Capital, CNBC, Reuters Locations: Washington, United States